NEW YORK, NY / ACCESS Newswire / August 26, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=163621&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

NEW YORK, NY / ACCESS Newswire / August 26, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=163608&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

LUND, SE / ACCESS Newswire / August 26, 2025 / BioInvent International (STO:BINV) – "This is an important next step for BioInvent," said Martin Welschof, Chief Executive Officer of BioInvent. "We are sharpening our clinical focus on our most advanced assets with the greatest potential impact and multiple upcoming catalysts, thus maintaining a strong foundation

Focusing on lead programs BI-1206 and BI-1808, with strong clinical data and upcoming value-creation milestones Phase 2a study of BI-1206 in combination with pembrolizumab in first-line NSCLC to initiate in H2 2025 LUND, SE / ACCESS Newswire / August 26, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery

STOCKHOLM, SE / ACCESS Newswire / August 26, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January – June 2025 is now available on the company’s website: www.alzecurepharma.com/en/section/investors/financial-reports/ "The second quarter of 2025 was yet another active and positive quarter for AlzeCure Pharma. In June, we

NEW YORK, NY / ACCESS Newswire / August 26, 2025 / If you suffered a loss on your Capricor Therapeutics, Inc. (NASDAQ:CAPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/capricor-therapeutics-inc-lawsuit-submission-form-2?prid=163607&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

101 C-suite executives rank AI as the top tech initiative to watch, yet most struggle to trust AI solutions and lack clear implementation strategies A new report from healthcare consultancy Sage Growth Partners reveals a growing divide between the promise of AI in healthcare and the preparedness of hospital and health system leaders to implement

Orosur Mining Inc – infill drilling continues to deliver, 71.85m @ 6.13g/t Au. Assays from four more holes from the Pepas MRE infill program include: PEP050 – 34m @ 2.33g/t Au from surface PEP051 – 61.3m @ 3.36g/t Au PEP052 – 71.85m @ 6.13g/t Au El Cedro soil sampling 45% complete – first samples submitted

Fabrix.ai's Enterprise-Grade Agentic Operational Intelligence Platform and Production-Ready AgentOps Capabilities Recognized as Leading Solution for Multiagent Orchestration in Telecommunications Fabrix.ai (formerly CloudFabrix), the inventor of the industry's first Agentic AI Operational Intelligence Platform and production-ready AgentOps, today announced its inclusion in Gartner's latest report – Market Trend: Agentic AI for CSP Autonomous Network Operations (July

Company Strengthens Relations with the U.S. Government through membership of Defense Industrial Base Consortium (DIBC) and Cornerstone LONDON, UK / ACCESS Newswire / August 26, 2025 / Guardian Metal Resources plc (LON:GMET)(OTCQB:GMTLF), a strategic development and mineral exploration company focused on tungsten in Nevada, USA, is pleased to provide an update on the advancement of